The present study was designed to test the hypothesis that AT2R activation with Compound 21 (C21) restores the AT1R/AT2R balance and reverses gestational hypertension by improving vascular function and vascular contraction and relaxation mechanisms. The gene discussed is AGTR1; the disease is preeclampsia.